Division

Nephroscience

K-smatco Lifesciences embarked on its journey in 2007 by focusing on the chronic therapeutic area of Nephrology. We were pioneers in addressing the needs of early-stage Chronic Kidney Disease (CKD) patients, a highly challenging endeavor, especially in India, where over 60 million individuals are suspected to have some form of kidney disease, yet only about 1% (6-7 lakhs) are diagnosed or undergoing renal therapy.

Despite these challenges, K-smatco Lifesciences has quickly positioned itself as a leader in Nephrology, providing care to the largest number of CKD patients in India. Our commitment to delivering high-quality, innovative treatments has allowed us to become a trusted partner in the healthcare journey of CKD patients nationwide.